AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26747333 — intervention group
Group type: EXPERIMENTAL
Intervention: 60,000 IU of vitamin D3
Number of subjects: 200
Study 26747333 — intervention group
Group type: EXPERIMENTAL
Intervention: 24,000 IU of vitamin D3 plus 300 μg of calcifediol
Number of subjects: 200
Study 26747333 — intervention group
Group type: COMPARATOR
Intervention: 24,000 IU of vitamin D3 (control group)
Number of subjects: 200
Study 26415294 — intervention group
Group type: EXPERIMENTAL
Intervention: Kruarone 0.6 mg/kg
Number of subjects: 80
Study 26415294 — intervention group
Group type: COMPARATOR
Intervention: Esmerone
Number of subjects: 80
Study 24146327 — intervention group
Group type: EXPERIMENTAL
Intervention: Active brown adipose tissue (BAT)
Number of subjects: 62
Study 24146327 — intervention group
Group type: COMPARATOR
Intervention: Negative control (no detectable BAT)
Number of subjects: 62
Study 20920765 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (10 mg) + Budesonide (200 μg)
Number of subjects: 50
Study 20920765 — intervention group
Group type: COMPARATOR
Intervention: Budesonide (200 μg)
Number of subjects: 50
Study 18713092 — intervention group
Group type: EXPERIMENTAL
Intervention: TASB (thoracic anti-supine band)
Number of subjects: 20
Study 18713092 — intervention group
Group type: COMPARATOR
Intervention: nCPAP (nasal CPAP)
Number of subjects: 20
Study 17015817 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon (16, 80, or 160 mg)
Number of subjects: 14
Study 17015817 — intervention group
Group type: COMPARATOR
Intervention: Triazolam (0.25, 0.5, or 0.75 mg)
Number of subjects: 14
Study 17015817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 12821462 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemifloxacin administered alone
Number of subjects: 16
Study 12821462 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemifloxacin administered simultaneously with calcium carbonate
Number of subjects: 16
Study 12821462 — intervention group
Group type: COMPARATOR
Intervention: Gemifloxacin administered 2 h before calcium carbonate
Number of subjects: 16
Study 12821462 — intervention group
Group type: COMPARATOR
Intervention: Gemifloxacin administered 2 h after calcium carbonate
Number of subjects: 16
Study 10804490 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture closure of the subcutaneous tissue
Number of subjects: 76
Study 10804490 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement of a subcutaneous closed suction drain
Number of subjects: 76
Study 10804490 — intervention group
Group type: COMPARATOR
Intervention: Neither suture closure nor drainage
Number of subjects: 76
Study 8692149 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous hyperthermic peritoneal perfusion (CHPP)
Number of subjects: 234
Study 8692149 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CHPP)
Number of subjects: 234
Study 8692149 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without intraperitoneal free cancer cells treated with CHPP
Number of subjects: 234
Study 8692149 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients without free cancer cells)
Number of subjects: 234
Study 1458623 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 201
Study 1458623 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 201
Study 1458623 — intervention group
Group type: EXPERIMENTAL
Intervention: Neither procedure
Number of subjects: 201
Study 1458623 — intervention group
Group type: COMPARATOR
Intervention: Control group (no surgery)
Number of subjects: 201
Study 6517150 — intervention group
Group type: EXPERIMENTAL
Intervention: Endolymphatic sac-mastoid shunt surgery
Number of subjects: 30
Study 6517150 — intervention group
Group type: COMPARATOR
Intervention: Placebo operation (mastoidectomy)
Number of subjects: 30
Study 31518454 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangular neck implant (test)
Number of subjects: 32
Study 31518454 — intervention group
Group type: COMPARATOR
Intervention: Round neck implant (control)
Number of subjects: 32
Study 31518454 — intervention group
Group type: EXPERIMENTAL
Intervention: Both implants (triangular and round neck)
Number of subjects: 32
Study 31518454 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangular neck implant
Number of subjects: 32
Study 30072156 — intervention group
Group type: EXPERIMENTAL
Intervention: CR + sedentary prompts from an activPAL3‐VT
Number of subjects: 40
Study 30072156 — intervention group
Group type: COMPARATOR
Intervention: Usual care CR
Number of subjects: 40
Study 27189287 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast
Number of subjects: 260
Study 27189287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study 24587355 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg AMP at encoding and placebo at retrieval (condition AP)
Number of subjects: 80
Study 24587355 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo at encoding and AMP at retrieval (condition PA)
Number of subjects: 80
Study 24587355 — intervention group
Group type: EXPERIMENTAL
Intervention: AMP at encoding and retrieval (condition AA)
Number of subjects: 80
Study 24587355 — intervention group
Group type: COMPARATOR
Intervention: Placebo at encoding and retrieval (condition PP)
Number of subjects: 80
Study 22341993 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 k Bq/kg radium-223
Number of subjects: 100
Study 22341993 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 k Bq/kg radium-223
Number of subjects: 100
Study 22341993 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 k Bq/kg radium-223
Number of subjects: 100
Study 22341993 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 k Bq/kg radium-223
Number of subjects: 100
Study 22341993 — intervention group
Group type: EXPERIMENTAL
Intervention: All dose groups
Number of subjects: 100
Study 20235191 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilt whole-body vibration (WBV) intervention, 30-minute session of instruction plus 3 sessions of WBV per week for 12 weeks, 6 repetitions of 45-60 seconds at 12.5 Hz
Number of subjects: 41
Study 20235191 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 41
Study 20235191 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilt whole-body vibration (WBV) intervention
Number of subjects: 41
Study 17563841 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg
Number of subjects: 155
Study 17563841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 155
Study 17563841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 15756512 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS methylphenidate (MPH)
Number of subjects: 0
Study 15756512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12546313 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous meperidine
Number of subjects: 84
Study 12546313 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 84
Study 9534917 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine
Number of subjects: 230
Study 9534917 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 230
Study 9534917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study 7885501 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for colon cancer
Number of subjects: 141
Study 7885501 — intervention group
Group type: EXPERIMENTAL
Intervention: Dukes staging system
Number of subjects: 141
Study 7885501 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumour size and shape, central lymph node involvement
Number of subjects: 141
Study 7885501 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up after surgery
Number of subjects: 141
Study 2234715 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective delivery 48 hours after administration of betamethasone (aggressive-management group)
Number of subjects: 58
Study 2234715 — intervention group
Group type: COMPARATOR
Intervention: Delivery later as indicated by maternal or fetal condition (expectant-management group)
Number of subjects: 58
Study 736293 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine, 0.4 mg
Number of subjects: 300
Study 736293 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate, 0.2 mg
Number of subjects: 300
Study 736293 — intervention group
Group type: COMPARATOR
Intervention: Saline solution, 1 ml
Number of subjects: 300
Study 736293 — intervention group
Group type: COMPARATOR
Intervention: No anticholinergic drug
Number of subjects: 300
Study 29218381 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step screening program using FRAX and DXA scan
Number of subjects: 34229
Study 29218381 — intervention group
Group type: EXPERIMENTAL
Intervention: DXA scanning in moderate- to high-risk women
Number of subjects: 34229
Study 29218381 — intervention group
Group type: COMPARATOR
Intervention: Control group (office-based case-finding strategy)
Number of subjects: 34229
Study 27752750 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapy
Number of subjects: 150
Study 27752750 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy
Number of subjects: 150
Study 27752750 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional MRI (fMRI)
Number of subjects: 150
Study 26067552 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program for 6 months
Number of subjects: 59
Study 26067552 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 59
Study 24067488 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led algorithm-based treatment
Number of subjects: 218
Study 24067488 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastroenterologist-led algorithm-based treatment
Number of subjects: 218
Study 21424588 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal cannula (5 L/min)
Number of subjects: 90
Study 21424588 — intervention group
Group type: EXPERIMENTAL
Intervention: Face mask (5 L/min)
Number of subjects: 90
Study 21424588 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 90
Study 18344727 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine monotherapy
Number of subjects: 83
Study 18344727 — intervention group
Group type: COMPARATOR
Intervention: Lithium carbonate monotherapy
Number of subjects: 83
Study 15607840 — intervention group
Group type: EXPERIMENTAL
Intervention: Illicit use of prescription pain medication from peers
Number of subjects: 9161
Study 15607840 — intervention group
Group type: EXPERIMENTAL
Intervention: Illicit use of prescription pain medication from family members
Number of subjects: 9161
Study 15607840 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous prescription of pain medication
Number of subjects: 9161
Study 15607840 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in a house or apartment
Number of subjects: 9161
Study 15607840 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower grade point averages
Number of subjects: 9161
Study 12440557 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (800 IU/d)
Number of subjects: 0
Study 12440557 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy
Number of subjects: 0
Study 12440557 — intervention group
Group type: EXPERIMENTAL
Intervention: Megesterol acetate
Number of subjects: 0
Study 12440557 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 0
Study 12440557 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study 12440557 — intervention group
Group type: COMPARATOR
Intervention: Clonidine, methyldopa, and belladonna
Number of subjects: 0
Study 9859550 — intervention group
Group type: EXPERIMENTAL
Intervention: Filmed modeling
Number of subjects: 60
Study 9859550 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping skills
Number of subjects: 60
Study 9859550 — intervention group
Group type: EXPERIMENTAL
Intervention: Filmed modeling plus coping skills
Number of subjects: 60
Study 9859550 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 7840069 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-LA-rich vegetable oil (flaxseed oil)
Number of subjects: 0
Study 7840069 — intervention group
Group type: COMPARATOR
Intervention: Dietary LA
Number of subjects: 0
Study 7840069 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary alpha-LA
Number of subjects: 0
Study 2229775 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase
Number of subjects: 73
Study 2229775 — intervention group
Group type: COMPARATOR
Intervention: Control (no streptokinase)
Number of subjects: 73
Study 840556 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily phenobarbital
Number of subjects: 355
Study 840556 — intervention group
Group type: COMPARATOR
Intervention: Intermittent phenobarbital
Number of subjects: 355
Study 840556 — intervention group
Group type: COMPARATOR
Intervention: No phenobarbital
Number of subjects: 355
Study 31343543 — intervention group
Group type: EXPERIMENTAL
Intervention: perindopril/indapamide/amlodipine (n = 101)
Number of subjects: 345
Study 31343543 — intervention group
Group type: COMPARATOR
Intervention: perindopril/indapamide (n = 109)
Number of subjects: 345
Study 27406787 — intervention group
Group type: EXPERIMENTAL
Intervention: Early diagnostic accuracy of clinical judgment of the ED physician for ACS in women
Number of subjects: 2795
Study 27406787 — intervention group
Group type: COMPARATOR
Intervention: Early diagnostic accuracy of clinical judgment of the ED physician for ACS in men
Number of subjects: 2795
Study 27406787 — intervention group
Group type: EXPERIMENTAL
Intervention: Late diagnostic uncertainty regarding the diagnosis of ACS in women
Number of subjects: 2795
Study 27406787 — intervention group
Group type: COMPARATOR
Intervention: Late diagnostic uncertainty regarding the diagnosis of ACS in men
Number of subjects: 2795
Study 26123286 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric(III)carboxymaltose infusion
Number of subjects: 198
Study 26123286 — intervention group
Group type: COMPARATOR
Intervention: Ferrofumarate (oral iron supplementation)
Number of subjects: 198
Study 23527241 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD chest radiograph
Number of subjects: 1424
Study 23527241 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (imaged but not actually receiving a chest radiograph)
Number of subjects: 1424
Study 21457153 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcostal TAP catheters with 1 mg.kg(‐1) bupivacaine 0.375% every 8 h
Number of subjects: 62
Study 21457153 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia with bupivacaine 0.125% and fentanyl 2 μg.ml(‐1)
Number of subjects: 62
Study 21457153 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcostal TAP catheters
Number of subjects: 62
Study 19318435 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome classification
Number of subjects: 2392
Study 19318435 — intervention group
Group type: EXPERIMENTAL
Intervention: High waist circumference
Number of subjects: 2392
Study 19318435 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated fasting glucose
Number of subjects: 2392
Study 19318435 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of large waist circumference and elevated glucose
Number of subjects: 2392
Study 16478779 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhosis patients
Number of subjects: 57
Study 16478779 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-liver transplantation patients
Number of subjects: 57
Study 15023581 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid from patients with AD
Number of subjects: 19
Study 11912568 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (512 mg/day)
Number of subjects: 97
Study 11912568 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (not specified dosage)
Number of subjects: 97
Study 11912568 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 9470264 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal-intervention group (educational letter)
Number of subjects: 300
Study 9470264 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal-intervention group (threat of enforcement)
Number of subjects: 300
Study 9470264 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 300
Study 9470264 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal-intervention group
Number of subjects: 300
Study 9470264 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal-intervention group
Number of subjects: 300
Study 9470264 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal-intervention group and Maximal-intervention group
Number of subjects: 300
Study 8163132 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-look endoscopy within the first 24 hours with repeated injection if a visible vessel was still identified
Number of subjects: 104
Study 3286039 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP) 0.3 micrograms/kg
Number of subjects: 100
Study 3286039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 29331313 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide-formoterol
Number of subjects: 4528
Study 29331313 — intervention group
Group type: COMPARATOR
Intervention: Formoterol alone
Number of subjects: 4528
Study 27007999 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteofortil®
Number of subjects: 24
Study 27007999 — intervention group
Group type: COMPARATOR
Intervention: Forteo®
Number of subjects: 24
Study 25899544 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-dimensional indoor and outdoor balance training (EXP)
Number of subjects: 84
Study 25899544 — intervention group
Group type: COMPARATOR
Intervention: Upper limb exercise (CON)
Number of subjects: 84
Study 23750971 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-room dyads
Number of subjects: 2
Study 23750971 — intervention group
Group type: EXPERIMENTAL
Intervention: Different-room dyads with audio
Number of subjects: 2
Study 23750971 — intervention group
Group type: COMPARATOR
Intervention: Different-room dyads without audio
Number of subjects: 2
Study 20458988 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen gel pack applied to sternal incision dressing before DB & C exercises
Number of subjects: 32
Study 20458988 — intervention group
Group type: COMPARATOR
Intervention: No gel pack
Number of subjects: 32
Study 18154801 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ventilation during cardiopulmonary bypass
Number of subjects: 50
Study 18154801 — intervention group
Group type: COMPARATOR
Intervention: Nonventilation during cardiopulmonary bypass
Number of subjects: 50
Study 15577413 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) and Lamivudine (3TC)
Number of subjects: 16
Study 11549104 — intervention group
Group type: COMPARATOR
Intervention: Theophylline (600 mg) alone
Number of subjects: 18
Study 11549104 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod (6 mg) and Theophylline (600 mg)
Number of subjects: 18
Study 11549104 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod (6 mg)
Number of subjects: 18
Study 9928569 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusional 5-FU 200 mg/m2 per day for up to 6 months in combination with 3-weekly bolus epirubicin (60 mg/m2) and cisplatin (60 mg/m2)
Number of subjects: 123
Study 9928569 — intervention group
Group type: COMPARATOR
Intervention: Infusional ECF
Number of subjects: 123
Study 8150098 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week weight loss program (n = 6)
Number of subjects: 12
Study 8150098 — intervention group
Group type: COMPARATOR
Intervention: 12-week waiting list (control group, n = 6)
Number of subjects: 12
Study 3229867 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol therapy
Number of subjects: 50
Study 31621349 — intervention group
Group type: EXPERIMENTAL
Intervention: ezParent Program implementation
Number of subjects: 36
Study 31621349 — intervention group
Group type: EXPERIMENTAL
Intervention: Interest in participating in the ezParent Program
Number of subjects: 36
Study 30431605 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified quadruple therapy (proton‐pump inhibitor bid, amoxicillin 1 g bid, metronidazole 500 mg tid, bismuth subcitrate 300 mg qid daily)
Number of subjects: 0
Study 30431605 — intervention group
Group type: COMPARATOR
Intervention: Bismuth‐containing quadruple therapy (proton‐pump inhibitor bid, tetracycline 500 mg qid, metronidazole 500 mg tid, bismuth subcitrate 300 mg qid daily)
Number of subjects: 0
Study 26729448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-containing arm
Number of subjects: 139
Study 26729448 — intervention group
Group type: COMPARATOR
Intervention: Standard regimens (tacrolimus, sirolimus and methotrexate)
Number of subjects: 139
Study 25305762 — intervention group
Group type: EXPERIMENTAL
Intervention: 25‐µg sublingual misoprostol with vaginal placebo
Number of subjects: 131
Study 25305762 — intervention group
Group type: COMPARATOR
Intervention: 50‐µg intravaginal misoprostol with sublingual placebo
Number of subjects: 131
Study 22449658 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (n=74, 3 g intravenous injection before the procedure and oral 1 g per day for 2 days after the procedure)
Number of subjects: 156
Study 22449658 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride alone (n=82, control group)
Number of subjects: 156
Study 22449658 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 156
Study 22449658 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride alone (control group)
Number of subjects: 156
Study 20139126 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-ended responses pooled with predefined responses
Number of subjects: 1664
Study 20139126 — intervention group
Group type: COMPARATOR
Intervention: Predefined responses
Number of subjects: 1664
Study 15667874 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% rectal lidocaine gel
Number of subjects: 114
Study 15667874 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% dimethyl sulfoxide (DMSO) with lidocaine
Number of subjects: 114
Study 15667874 — intervention group
Group type: EXPERIMENTAL
Intervention: Perianal injection of 1% lidocaine
Number of subjects: 114
Study 15667874 — intervention group
Group type: EXPERIMENTAL
Intervention: Periprostatic nerve block
Number of subjects: 114
Study 15667874 — intervention group
Group type: COMPARATOR
Intervention: Control group (lidocaine gel)
Number of subjects: 114